Literature DB >> 11071435

Apparent diffusion coefficient measurements in progressive supranuclear palsy.

T Ohshita1, M Oka, Y Imon, S Yamaguchi, Y Mimori, S Nakamura.   

Abstract

We measured the apparent diffusion coefficient (ADC), using diffusion-weighted imaging (DWI) and signal intensity on T2-weighted MRI in the cerebral white matter of patients with progressive supranuclear palsy (PSP) and age-matched normal subjects. In PSP, ADC in the prefrontal and precentral white matter was significantly higher than in controls. There was no significant difference in signal intensity on T2-weighted images. The ADC did correlate with signal intensity. The distribution of the elevation of ADC may be the consequence of underlying pathological changes, such as neurofibrillary tangles or glial fibrillary tangles in the cortex. Our findings suggest that ADC measurement might be useful for demonstrating subtle neuropathological changes.

Entities:  

Mesh:

Year:  2000        PMID: 11071435     DOI: 10.1007/s002340000372

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  7 in total

1.  Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging.

Authors:  Masato Kanazawa; Takayoshi Shimohata; Kenshi Terajima; Osamu Onodera; Keiko Tanaka; Shoji Tsuji; Kouichirou Okamoto; Masatoyo Nishizawa
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.

Authors:  Kazumichi Tsukamoto; Eiji Matsusue; Yoshiko Kanasaki; Suguru Kakite; Shinya Fujii; Toshio Kaminou; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2012-01-25       Impact factor: 2.804

3.  Tracking the neurodegeneration of parkinsonian disorders--a pilot study.

Authors:  C Nilsson; K Markenroth Bloch; S Brockstedt; J Lätt; H Widner; E-M Larsson
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

4.  Track density imaging in progressive supranuclear palsy: A pilot study.

Authors:  Salvatore Nigro; Maria Giovanna Bianco; Gennarina Arabia; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Maria Salsone; Antonio Augimeri; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2018-11-26       Impact factor: 5.038

Review 5.  A review of the use of magnetic resonance imaging in Parkinson's disease.

Authors:  Nadya Pyatigorskaya; Cécile Gallea; Daniel Garcia-Lorenzo; Marie Vidailhet; Stéphane Lehericy
Journal:  Ther Adv Neurol Disord       Date:  2014-07       Impact factor: 6.570

6.  Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy.

Authors:  Shoichi Ito; Takahiro Makino; Wakako Shirai; Takamichi Hattori
Journal:  Neuroradiology       Date:  2008-09-09       Impact factor: 2.804

Review 7.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.